AzTrials
AzTrials

GeriatricsNCT07158931

'Nordic Walking' on Geriatric Individuals

A study testing nordic walking and General walking in people with Geriatrics and Geriatric Rehabilitation, run by Istanbul Rumeli University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to investigate the effects of Nordic Walking training on muscle strength and endurance, balance, fear of falling, aerobic capacity, fatigue, quality of life and activity level in geriatric individuals. 32 sedentary individuals between the ages of 65-80 participated in the study. Read more about this study

Who is it for?
Ages 65 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Geriatrics, Geriatric Rehabilitation
What is being tested?
nordic walking and General walking
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Oct 2022to 29 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • being between 65 and 80 years of age,
  • having a score of 24 or above on the Standardized Mini-Mental State Examination (SMMSE),
  • and voluntarily agreeing to participate in the study.

Who cannot join

  • a history of cerebrovascular accident,
  • acute retinal hemorrhage or previous ophthalmic surgery,
  • active infection, malignancy,
  • multiple organ failure, terminal illness, or a history of lower or upper extremity fracture within the last three months.
  • had any musculoskeletal condition that would prevent them from engaging in exercise,
  • a diagnosis of Alzheimer's disease, Parkinson's disease, or dementia,
  • a diagnosis of benign paroxysmal positional vertigo (BPPV),
  • had engaged in regular exercise training (≥150 minutes per week) within the past six months.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Öziri

    Ataşehir, Istanbul

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of Effectiveness of 'Nordic Walking' Training On Geriatric Individuals: a Randomized Comparative Study

This study aimed to investigate the effects of Nordic Walking training on muscle strength and endurance, balance, fear of falling, aerobic capacity, fatigue, quality of life and activity level in geriatric individuals.

32 sedentary individuals between the ages of 65-80 participated in the study. Nordic Walking (NW) and Traditional Walking (GY) groups were created by systematic randomization method. In line with the intended research parameters, participants were given 30 sec sit-to-stand (30secCST), 30 sec biceps curl (30 sec ACT), timed up and go (TUG) 6 min walk (6MWT), Tinetti Fall Effectiveness (Tinetti FES), Tampa Kinesiophobia Scale (TSK), World Health Organization Quality of Life Elderly Module (WHOQOL-Old) were administered. Evaluations were repeated before and after the study. The study was conducted under the supervision of a physiotherapist, 3 days a week for 12 weeks in both groups.

Being tested
nordic walking, General walking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • nordic walkingOther

    Before the NW program, participants completed a one-week familiarization phase to practice pole use. Training was held three times: 15 minutes on days 1 and 2, and 20 minutes on day 3, at 40-60% heart rate reserve (measured with a pulse oximeter). Warm-up included a 1-minute slow walk, toe raises, seated dorsiflexion, mini squats, scapular adduction, and shoulder/wrist stretches. Each session ended with a cool-down of a 2-minute slow walk and 20-second stretches for major muscle groups (quadriceps, hamstrings, lumbar extensors, gastrocnemius, shoulders, wrists).The walking poles used in this study were the Evolite Ultralite Titanium Antishock Trekking Pole, which has a titanium alloy body and a three-piece telescopic structure, adjustable to the desired length between 68 and 135 cm.

  • General walkingOther

    The program was performed on concrete or compacted soil surfaces, under the same physiotherapist's supervision. Walking speed was adjusted to remain below 60% of maximal heart rate and to allow participants to converse comfortably during exercise.

Study groups in NCT07158931
Study groupRoleWhat they receive
ExperimentalExperimentalNordic Walking
Receives: Other: nordic walking
ControlActive comparatorGeneral walking
Receives: Other: General walking

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sit-to-stand test (STS):

    This is a widely used clinical assessment tool in geriatrics for evaluating lower limb function, muscle strength, balance, and overall physical performance in older adults. Participants were instructed to sit on a chair approximately 48 cm in height, keeping their back straight, feet flat on the floor, and arms crossed over the chest. They were then asked to stand up and sit down repeatedly for 30 seconds. The total number of complete stands performed within the 30-second period was recorded

    Measured: at the beginning and at the end of the 12th week

  2. Biceps curl test (BCT):

    This is a widely used assessment in geriatrics to evaluate upper body strength and endurance, particularly of the arm muscles (7). The arm curl test was performed with participants seated on a chair without armrests. Holding a dumbbell in the hand with the palm facing the body, participants executed elbow flexion with supination through a full range of motion, ensuring the elbow was fully bent and then fully extended for each repetition. Women used 2 kg dumbbells and men used 3 kg dumbbells. The total number of controlled repetitions completed in 30 seconds was recorded.

    Measured: at the beginning and at the end of the 12th week

  3. 6-Minute Walk Test (MWT):

    It is a widely used, simple, and validated clinical assessment to measure aerobic capacity and functional exercise tolerance in older adults (8). The participant was instructed to walk along a 30-meter flat surface for six minutes. At the end of the six-minute period, the total distance walked was recorded in meters.

    Measured: at the beginning and at the end of the 12th week

  4. Timed Up and Go Test (TUG):

    This is a clinical and research tool to assess mobility, balance, walking ability, and fall risk in older adults (9). While seated on a chair approximately 48 cm in height, the participant was instructed, upon hearing the "start" command, to stand up, walk 3 meters forward at a normal walking speed, return, and sit down again. The test was performed twice, and the average time was recorded.

    Measured: at the beginning and at the end of the 12th week

Secondary outcomes (3)
  1. Tinetti Falls Efficacy Scale (TFES):

    It is a validated tool used to assess an individual's confidence in performing daily activities without falling. Participants rated their perceived safety during various daily activities on a scale from 1 (very confident) to 10 (not confident at all). Scores were converted to a total between 0 (low fall-related self-efficacy) and 100 (high fall-related self-efficacy), with higher scores indicating greater fear of falling (10).

    Measured: at the beginning and at the end of the 12th week

  2. Tampa Kinesiophobia Scale (TKS):

    It is a 17-item self-report questionnaire rated on a 4-point Likert scale, designed to assess fear of movement or re-injury. Higher scores indicate greater levels of kinesiophobia.

    Measured: at the beginning and at the end of the 12th week

  3. World Health Organization Quality of Life Instrument-Older Adults Module (WHOQL- OLD):

    It is a 24-item questionnaire assessed on a five-point Likert scale, covering six domains: sensory abilities, autonomy, past-present-future activities, social participation, death and dying, and intimacy. Each domain is scored from 4 to 20, and higher total scores indicate better quality of life

    Measured: at the beginning and at the end of the 12th week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2025
  2. Study start1 Oct 2022
  3. Primary completion1 Mar 2024
  4. Study completion29 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
28 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07158931
Sponsor's protocol ID
IstanbulRumeliU
Status last verified
Aug 2025
First submitted
20 Aug 2025
Last updated
8 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Oziri N, Baskan E, Balkisli BC. Investigation of the effectiveness Of 'Nordic Walking' training on geriatric individuals: a randomized comparative study. Eur Geriatr Med. 2026 May 19. doi: 10.1007/s41999-026-01507-w. Online ahead of print.

    PubMed 42154148

Questions about this trial

What is this clinical trial studying?

A study testing nordic walking and General walking in people with Geriatrics and Geriatric Rehabilitation, run by Istanbul Rumeli University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sit-to-stand test (STS): (time frame: at the beginning and at the end of the 12th week). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07158931, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in